Similarly, although SDF-1 may ameliorate kidney injury and promote repair after nondiabetic ischemia [26], potentiation of the chemokine can contribute to a proliferative response that leads to glomerulosclerosis, podocyte loss, and albuminuria [27, 28], thus implicating SDF-1 in the pathogenesis of diabetic nephropathy
So, let's say your protocol calls for a 100mcg dose of each peptide
Because GHK-Cu interacts with multiple regenerative and cellular-maintenance pathways, it is frequently investigated as part of broader multi-pathway healthy-aging, tissue-support, skin-integrity, and recovery-focused research protocols
It's a cascade of negative hormonal events that directly oppose the anabolic, restorative environment youre trying to build